Proposed Experimental Protocols for Testing the Critical Scaling Gap and Phase-Dependent Scaling in Quantum and Biological Systems

"This work is a component of the Phase-Dependent Scaling Program (2026) and is theoretically grounded in the 1.91x Critical Scaling Gap identified in Omandac (2026, Paper 1)." This manuscript proposes experimental protocols for testing whether the Phase-Dependent Scaling Model and Critical Scaling Gap observed in Dicke-type quantum systems extend to synthetic and biological substrates. High-resolution numerical simulations (N=100) reveal that open quantum systems converge to one of two stable topological plateaus: an Upper Plateau in the coherent phase (alpha approx -0.02) and a Lower Plateau in the fragmented phase. The ratio between these plateaus—the Critical Scaling Gap—remains constant at approximately 1.91× across large system sizes. We propose three complementary experimental pathways to investigate this behavior: (1) superconducting qubit array experiments to verify plateau convergence and the 1.91× ratio, (2) quantum optical spectroscopy of microtubule assemblies, and (3) analysis of EEG data during anesthesia transitions. These protocols shift the experimental focus from transient scaling exponents to the detection of stable topological phases, providing a rigorous pathway for validating the physical foundations of consciousness.